BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/26/2017 6:20:00 PM | Browse: 1241 | Download: 2362
Publication Name World Journal of Gastroenterology
Manuscript ID 28741
Country United States
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett’s esophagus: Case series and findings
Manuscript Source Unsolicited Manuscript
All Author List Shivali Marketkar, Dan Li, Dongfang Yang and Weibiao Cao
Funding Agency and Grant Number
Corresponding Author Weibiao Cao, MD, Department of Pathology, Rhode Island Hospital and Warren Alpert Medical School of Brown University, 593 Eddy St, APC12, Providence, RI 02903, United States. wcao@hotmail.com
Key Words TGR5; Esophageal adenocarcinoma; Bile acid
Core Tip The expression of a bile acid receptor TGR5 at moderate to strong intensity was significantly higher in high-grade dysplasia and esophageal adenocarcinoma (EA) cases than in BE or in low-grade dysplasia, suggesting that TGR5 may play an important role in the progression from Barrett’s esophagus to high-grade dysplasia and EA. TGR5 might be a potential marker for this progression. TGR5 staining intensity was not associated with the clinical stage, the pathological stage and the status of lymph node metastasis, indicating that TGR5 may not be a marker for the prognosis of EA.
Publish Date 2017-02-26 18:20
Citation Marketkar S, Li D, Yang D, Cao W. TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett’s esophagus: Case series and findings. World J Gastroenterol 2017; 23(8): 1338-1344
URL http://www.wjgnet.com/1007-9327/full/v23/i8/1338.htm
DOI http://dx.doi.org/10.3748/wjg.v23.i8.1338
Full Article (PDF) WJG-23-1338.pdf
Full Article (Word) WJG-23-1338.doc